WuXi PharmaTech To Transfer Biologics Testing And Manufacturing From U.S. AppTec To New China Lab

BEIJING - While reporting surging earnings growth for the second quarter of 2008, WuXi PharmaTech said the company would begin transferring biologics testing and manufacturing from recently acquired American AppTec Laboratory Services to China